Guselkumab Improves Anemia in Patients with Active Psoriatic Arthritis: Results From Two Phase 3 Randomized Controlled Clinical Trials

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Liu, Yang [2 ]
Rahman, Proton [3 ]
Mease, Philip [4 ]
Gossec, Laure [5 ,6 ]
Xu, Lillian [7 ]
Hsia, Elizabeth [8 ,9 ]
Shawi, May [10 ]
Han, Chenglong [11 ]
Neuhold, Marlies [12 ]
Deodhar, Atul [13 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Janssen R&D US, San Diego, CA USA
[3] Mem Univ Newfoundland, St John, NF, Canada
[4] Univ Washington, Seattle, WA 98195 USA
[5] Sorbonne Univ, Paris, France
[6] Hop La Pitie Salpetriere, Rheumatol Dept, Paris, France
[7] Janssen Res & Dev LLC, San Diego, CA USA
[8] Janssen Res & Dev LLC, Philadelphia, PA USA
[9] Univ Penn, Philadelphia, PA 19104 USA
[10] Janssen Inc, Raritan, NJ USA
[11] Janssen R&D US, Spring House, PA USA
[12] Janssen Sci Affairs, Zug, Switzerland
[13] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2022年 / 49卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17
引用
收藏
页码：788 / 789
页数：2
相关论文
共 50 条
  • [1] Guselkumab (TREMFYA®) Improves Anemia in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Randomized Controlled Clinical Trials
    Kavanaugh, Arthur
    Liu, Yan
    Rahman, Proton
    Mease, Philip
    Gossec, Laure
    Xu, Xie
    Hsia, Elizabeth
    Shawi, May
    Han, Chenglong
    Neuhold, Marlies
    Deodhar, Atul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2763 - 2766
  • [2] GUSELKUMAB PROVIDES CONSISTENT AND DURABLE PAIN IMPROVEMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF 2 PHASE 3, RANDOMIZED, CONTROLLED CLINICAL TRIALS
    Nash, P.
    Tam, L. S.
    Tsai, W. C.
    Leung, Y. Y.
    Furtner, D.
    Sheng, S.
    Wang, Y.
    Shawi, M.
    Kollmeier, A.
    Sherlock, J.
    Cua, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 839 - 840
  • [3] Guselkumab (TREMFYA®) Provides Consistent and Durable Pain Improvement in Patients with Active Psoriatic Arthritis: Results of 2 Phase 3, Randomized, Controlled Clinical Trials
    Nash, Peter
    Tam, Lai-Shan
    Tsai, Wen-Chan
    Leung, Ying-Ying
    Furtner, Daniel
    Sheng, Shihong
    Wang, Yanli
    Shawi, May
    Kollmeier, Alexa
    Sherlock, Jonathan
    Cua, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2769 - 2772
  • [4] Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials
    Siebert, Stefan
    Sweet, Kristen M.
    Ritchlin, Christopher T.
    Hsia, Elizabeth C.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Seridi, Loqmane
    Song, Qingxuan
    Gao, Sheng
    Chen, Warner
    Miron, Michelle
    [J]. ACR OPEN RHEUMATOLOGY, 2023, 5 (09) : 490 - 498
  • [5] Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials
    Eder, Lihi
    Tony, Hans-Peter
    Odhav, Satish
    Galindez Agirregoikoa, Eva
    Korkosz, Mariusz
    Schwartzman, Sergio
    Sprabery, Aubrey Trevelin
    Gellett, Amanda M.
    Park, So Young
    Bertram, Clinton C.
    Ogdie, Alexis
    [J]. RHEUMATOLOGY AND THERAPY, 2022, 9 (03) : 919 - 933
  • [6] Ixekizumab Treatment Significantly Improves Enthesitis and Dactylitis in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Trials
    Gladman, Dafna D.
    Orbai, Ana-Maria
    Gallo, Gaia
    Birt, Julie
    Rathmann, Suchitrita
    Marzo-Ortega, Helena
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials
    Lihi Eder
    Hans-Peter Tony
    Satish Odhav
    Eva Galindez Agirregoikoa
    Mariusz Korkosz
    Sergio Schwartzman
    Aubrey Trevelin Sprabery
    Amanda M. Gellett
    So Young Park
    Clinton C. Bertram
    Alexis Ogdie
    [J]. Rheumatology and Therapy, 2022, 9 : 919 - 933
  • [8] INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS
    Rahman, P.
    Ritchlin, C.
    Helliwell, P.
    Boehncke, W. H.
    Mease, P.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Zhou, B.
    Ramachandran, P.
    McInnes, I.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1218 - 1218
  • [9] INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS
    Rahman, P.
    Ritchlin, C. T.
    Helliwell, P.
    Boehncke, W. H.
    Mease, P. J.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E. C.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Agarwal, P.
    Zhou, B.
    Ramachandran, P.
    Mcinnes, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 772 - 773
  • [10] POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR
    Ritchlin, C. T.
    Rahman, P.
    Helliwell, P.
    Boehncke, W. H.
    Mcinnes, I.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E. C.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Agarwal, P.
    Zhou, B.
    Ramachandran, P.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1300 - 1301
12345